21561 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a NS, NS, NS, N chelating group chelates from cyclic ligands, e.g. DOTA
Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer
#302PSMA ligands for imaging and endoradiotherapy
#303Radioactive phospholipid metal chelates for cancer imaging and therapy
#304METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY
#305Bicyclic peptide ligands specific for MT1-MMP
#306METHODS AND KITS FOR DIAGNOSIS OF CANCER AND PREDICTION OF THERAPEUTIC VALUE
#30768GA- AND 64CU -NODAGA-E[C(RGDYK)]2 FOR USE AS PET TRACERS IN THE IMAGING OF ANGIOGENESIS IN HUMANS
#308Metal complex forming compound, metal complex compound formed thereof, radioactive drug containing the metal complex compound, and method of using and preparing the metal complex compound
#309DOTMP kit formulations for radioisotopes
#310Radioactive labeling method for neuropeptide Y derivative compound and medicine for multi-type breast cancer therapy thereof
#311Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents
#312Discrete PEG Constructs
#313LONG-CIRCULATING THERANOSTIC AGENTS FOR DIAGNOSING AND IMAGING METASTATIC TUMORS
#314Dual mode radiotracer and—therapeutics
#315Dual targeting ligand for cancer diagnosis and treatment
#316Bicyclic peptide ligands specific for MT1-MMP
#317Reinforced macrocyclic ligands, complexes thereof, and uses of same
#318Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer
#319Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereof
#320RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE
#321Methods for Synthesis of Radionuclide Complex
#322Radioactive labeled long-acting peptide targeted pharmaceutical and production method thereof
#323TREATMENTS FOR A HEMATOLOGICAL MALIGNANCY
#324Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
#325Ultrasmall nanoparticles labeled with Zirconium-89 and methods thereof
#326Composition for cross talk between estrogen receptors and cannabinoid receptors
#327Macrocyclic ligands with pendant chelating moieties and complexes thereof
#328Stable, concentrated radionuclide complex solutions
#329Method for labeling radioisotope radiolabeling compound and kit comprising the same for labeling radioisotope
#330Treatment of PMSA expressing cancers
#331Multifunctional chelators, complexes, and compositions thereof, and methods of using same
#332Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer
#333Kit for radiolabelling
#334Hexa-lactoside-triazanonane triacetic acid (NOTA) derivative, method for radiolabeling hexa-lactoside positron emission tomography (PET) imaging agent for liver receptor with Ga-68, and hexa-lactoside PET imaging agent for liver receptor
#335Treatment of cancer cells overexpressing somatostatin receptors using ocreotide derivatives chelated to radioisotopes
#336LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCER
#337Radioactive compound for diagnosis of malignant melanoma and use thereof
#338PET tracer for imaging of neuroendocrine tumors
#339Compositions and methods of treating melanoma
#340RADIO-PHARMACEUTICAL COMPLEXES
#341Compositions for therapeutics, targeted PET imaging and methods of their use
#342Compounds for Positron Emission Tomography
#343One step 64Cu-BaBaSar-RGD2 production method
#344Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
#345Chelating platform for delivery of radionuclides
#346Long-lived gadolinium based tumor targeting imaging and therapy agents
#347Composition containing buffer
#348TCO conjugates and methods for delivery of therapeutic agents
#349Radioligands for pretargeted pet imaging and methods of their therapeutic use
#350PET tracer for imaging of neuroendocrine tumors
#351IGF-1R monoclonal antibodies and uses thereof
#352High purity therapeutic bone agents
#353MULTIPLE-FUNCTIONAL PROBE AND USES THEREOF
#354Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
#355PAMAM dendrimer based CEST imaging agents and uses thereof
#356Compounds, compositions and associated methods using zirconium-89 in immuno-positron emission tomography
#357Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
#358Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
#359Method of diagnosing and/or monitoring therapy of atherosclerosis
#360Radioactive probe for detecting hydrogen sulfide
#3616-oxa-3,9,15-triaza-bicyclo[9.3.1]pentadeca-1(14),11(15),12-triene derivatives based compounds and their application as ligands of essential metal ion based MRI and MN based PET contrast agents
#362Probes for 18F Positron Emission Tomography Imaging
#363Peptide thiourea derivative, radioisotope labeled compound containing same, and pharmaceutical composition containing same as active ingredient for treating or diagnosing prostate cancer
#3642,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of essential metal ion based MRI contrast agents and 52MN based PET contrast agents
#365Bicyclic peptide ligands specific for MT1-MMP
#366Methods for low temperature fluorine-18 radiolabeling of biomolecules
#367Kit for radiolabelling
#368Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof
#369Mono-, di- or polysaccharide used as metal inhibitor in the preparation of 68Ga-chelate-functionalized targeting agent
#370Kit for radiolabelling with 68GA comprising a metal inhibitor
#371Macrocyclic ligands with pendant chelating moieties and complexes thereof
#372DOTMP KIT FORMULATIONS FOR RADIOISOTOPES
#373RADIOACTIVE PHOSPHOLIPID METAL CHELATES FOR CANCER IMAGING AND THERAPY
#374Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
#375Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
#376Molecular probes for multimodality imaging and tracking of stem cells
#377Labeled evans blue dye derivative for in vivo serum albumin labeling
#378Development of neurokinin-1 receptor-binding agent delivery conjugates
#379Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy
#380Cage-like bifunctional chelators, copper-64 radiopharmaceuticals and PET imaging using the same
#381Long-lived gadolinium based tumor targeted imaging and therapy agents
#382Conjugate comprising a neurotensin receptor ligand and use thereof
#383TCO conjugates and methods for delivery of therapeutic agents
#384TCO conjugates and methods for delivery of therapeutic agents
#385Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy
#386Multivalent ligands targeting VEGFR
#387Molecular Imaging Probes
#388Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof
#389Tin-117m somatostatin receptor binding compounds and methods
#390METHODS OF IMAGING WITH Ga-68 LABELED MOLECULES
#391Imaging and treatment of pathophysiologic conditions by Cerenkov radiation
#392Cage amine ligands for metallo-radiopharmaceuticals
#393RADIOLIGANDS FOR PRETARGETED PET IMAGING AND METHODS OF THEIR THERAPEUTIC USE
#394SHK-BASED PHARMACEUTICAL COMPOSITIONS AND METHODS OF MANUFACTURING AND USING THE SAME
#395NON-INVASIVE DIAGNOSTIC AGENTS OF CANCER AND METHODS OF DIAGNOSING CANCER, ESPECIALLY LEUKEMIA AND LYMPHOMA
#396COMPOUNDS AND COMPOSITIONS FOR IMAGING GCC-EXPRESSING CELLS
#397Picolinate cross-bridged cyclams, chelates with metallic cations and use thereof
#398Compounds for Positron Emission Tomography
#399LABELED EVANS BLUE DYE DERIVATIVE FOR IN VIVO SERUM ALBUMIN LABELING
#400Process for the preparation of complexes of Ga
#401High purity therapeutic bone agents
#402Multifunctional chelators, complexes, and compositions thereof, and methods of using same
#403LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCER
#404Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
#405Synthesis of imidazo[1,2-a]pyrazin-4-ium salts for the synthesis of 1,4,7-triazacyclononane (tacn) and N- and/or C- functionalized derivatives thereof
#406Agents for the Molecular Imaging of Serine-Protease in Human Pathologies
#407Nitrogen-containing compound or salt thereof, or metal complex thereof
#408Entrapment of Radionuclides in Nanoparticle Compositions
#409Bifunctional chelating agents based on the 1,4-diazepine scaffold (DAZA) for non-invasive molecular imaging
#410GRP-R agonistic 177-lutetium-labeled bombesin derivatives for diagnosis and treatment of prostate cancer
#411Chelates of lead (II) and bismuth (III) based on trans-di-N-picolinate tetraazacycloalkanes
#412Metal complexes and fluorination thereof
#413METAL COMPLEXES AND THEIR FLUORINATION
#414Preparations of gold/mesoporous silica hybrid nanoparticle and applications
#415SHK-based pharmaceutical compositions and methods of manufacturing and using the same
#416Tetrahydroxamate chelators of zirconium89 and niobium90 for use in diagnostic applications
#417Methods and compositions for radiohalogen protein labeling
#418Compositions and methods for detecting plectin-1 as a biomarker for cancer
#419KIT FOR TUMOR IMAGING
#420Compositions and methods for in vivo imaging
#421Neurotensin receptor ligands
#422Tetraaza macrocyclic compound, preparation method thereof and use thereof
#423Methods of Synthesizing and Using Peg-Like Fluorochromes
#424Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of Alzheimer's disease
#425Metal-binding bifunctional compounds as diagnostic agents for Alzheimer's disease
#426Macrocycles
#427Methods and compositions for positron emission tomography myocardial perfusion imaging
#428Molecular probes for multimodality imaging and tracking of stem cells
#429Radiolabeled prostate specific membrane antigen inhibitors
#430Discrete PEG constructs
#431Functionalisation of cage amine ligands for metallo-radiopharmaceuticals
#432Version of FDG detectable by single-photon emission computed tomography
#433Radiofluorination method
#434Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
#435Pet tracer for imaging of neuroendocrine tumors
#436Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
#437Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof
#438Cage amine ligands for metallo-radiopharmaceuticals
#439CLICKED SOMATOSTATIN CONJUGATED ANALOGS FOR BIOLOGICAL APPLICATIONS
#440MATRIX METALLOPROTEASE (MMP) TARGETED AGENTS FOR IMAGING AND THERAPY
#441Compositions and methods for tumor imaging and targeting by a class of organic heptamethine cyanine dyes that possess dual nuclear and near-infrared properties
#442CXCR4 inhibiting carriers for nucleic acid delivery
#443Compositions, methods of synthesis and use of carbohydrate targeted agents
#444Cryptate compounds
#445Compositions and Methods for in Vivo Imaging
#446Macrocyclic compounds and metal complexes for bioimaging and biomedical applications
#447ANTI-TUMOR AGENT AND ANTI-TUMOR KIT
#448Process for the preparation of complexes of Ga
#449Methods and compositions for radiohalogen protein labeling
#450Synthesis of imidazo[1,2-a]pyrazin-4-ium salts for the synthesis of 1,4,7-triazacyclononane (tacn) and N- and/or C-functionalized derivatives thereof
#451Tin-117m somatostatin receptor binding compounds and methods
#452Compounds for diagnosing diseases associated with the expression of MUC5AC
#453In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
#454Contrast agents
#455Fibrosis specific multimeric peptidomimetic radiotracers
#456Treatment and diagnosis of macrophage mediated disease
#457Triazacyclononane-based phosphinate ligand and its use for molecular imaging
#458Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
#459Method and kit for preparing a radiopharmaceutical
#460Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
#461Tricarbonyl complexes with tridentate chelators for myocardium imaging
#462Tricarbonyl complexes with tridentate chelators for myocardium imaging
#463Radiolabeled prostate specific membrane antigen inhibitors
#464Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of alzheimer's disease
#465Diagnosis of macrophage mediated disease
#466Treatment and Diagnosis of Macrophage Mediated Disease
#467Bifunctional polyazamacrocyclic chelating agents
#468Compositions and methods for detecting plectin-1 as a biomarker for cancer
#469Tetraaza macrocyclic compound, preparation method thereof and use thereof
#470Methods and compositions for improved F labeling of proteins, peptides and other molecules
#471PROCESS FOR CHELATING COPPER IONS USING CB-TE2A BIFUNCTIONAL CHELATE
#472In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
#473Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
#474Porphyrazine optical and dual optical/MR contrast and therapeutic agents
#475Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
#476IMAGING AND RADIOTHERAPY METHODS
#477Complex of bifunctional chelating agent and mannosyl human serum albumin
#478Metal chelate linked to a hexose carrier for use as a metallopharmaceutical diagnostic or therapeutic agent
#479CYLIC POLYAMINES FOR BINDING PHOSPHATIDYLSERINE
#480Method to make porous materials and their applications
#481Metal complexes
#482RADIO-LABELED MATERIALS AND METHODS OF MAKING AND USING THE SAME
#483Contrast agents
#48468Ga-Labelling of a Free and Macromolecule Conjugated Macrocyclic Chelator at Ambient Temperature
#485Methods and kits for diagnosis of cancer and prediction of therapeutic value
#486Cage-like bifunctional chelators, copper-64 radiopharmaceuticals and PET imaging using the same
#487Technetium-99m (I) tricarbonyl complexes with tridentate chelators for myocardium imaging
#488Poly-Halo Metal X-ray Contrast Agents
#489Perfluoroalkyl-Containing Complexes, Process For Their Production As Well As Their Use
#490Radionuclide Therapy for Urinary Bladder Cancer
#491Bifunctional polyazamacrocyclic chelating agents
#492Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
#493High dose radionuclide complexes for bone marrow treatment
#494BIOCONJUGATES OF METAL COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS
#495Compositions for targeted imaging and therapy
#496PHTHALAMIDE-LANTHANIDE COMPLEXES FOR USE AS LUMINESCENT MARKERS
#497MULTI-USE MULTIMODAL IMAGING CHELATES
#498Multi-use multimodal imaging chelates
#499Bridged aromatic substituted amine ligands with donor atoms
#500Treatment and diagnosis of macrophage mediated disease
#501Compounds Useful as Metal Chelators
#502Fluoride carrier for positron emission tomography
#503Diagnosis of macrophage mediated disease
#504Perfluoroalkyl-containing complexes, process for their production as well as their use
#505Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation
#506Chelate based scaffolds in tumor targeting
#507High dose radionuclide complexes for bone marrow suppression
#508Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
#509Perfluoroalkyl-containing complexes, process for their production as well as their use
#5101,4,7,10-Tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them
#511Multifunctional cross-bridged tetraaza macrocyclic compounds and methods of making and using
#512Bridged aromatic substituted amine ligands with donor atoms
#513Treatment of bone-associated cancers
#514Macrocyclic chelants for metallopharmaceuticals
#515Method for preparing conjugates of proteins and chelating agents
#516High dose radionuclide complexes for bone marrow suppression
#517Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same
#518Aminocarboxylate ligands having substituted aromatic amide moieties
#519High dose radionuclide complexes for bone marrow suppression
#520Phthalamide-lanthanide complexes for use as luminescent markers
#521Chelants and macrocyclic metal complex radiopharmaceuticals thereof
#522Radiopharmaceutical composition and methods
#523Copper-64 compositions and formulations
#524Infusion devices and methods of using them